Gene · 3433
IFIT2: interferon induced protein with tetratricopeptide repeats 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. IFIT2: interferon induced protein with tetratricopeptide repeats 2. Genes, record 3433. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3433
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P09913 | Interferon-induced protein with tetratricopeptide repeats 2 | 472 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents21
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 50109 | P09913 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 9269 | P09913 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 9269 | P09913 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 41253 | P09913 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 144224 | P09913 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 5313 | P09913 | Espacenet |
| WO 2021070107 A1 | 2021-04-15 | 2 | P09913 | Espacenet |
| US 10846371 B2 | 2020-11-24 | 6 | P09913 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 230544 | P09913 | Espacenet |
| KR 1020190016302 A | 2019-02-18 | 56 | P09913 | Espacenet |
1 to 10 of 21
See all 21 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,804
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | IFIT2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 11 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 8 | 2025 |
| P01AI120943 | Molecular Mechanisms of Filoviral-host Interactions | 7 | 2025 |
| T32AI007647 | Training Program in Mechanisms of Virus-Host Interactions | 7 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 6 | 2025 |
| P51OD011092 | Support for National Primate Research Center | 6 | 2025 |
| P51OD011132 | Emory National Primate Research Center | 6 | 2025 |
| U19AI057266 | Vaccine and Infection Induced Immunity in the Young and Aged | 6 | 2025 |
| U19AI135972 | SARS-CoV adaptations through a Systems Biology Lens (SYBIL) | 6 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 6 | 2025 |
1 to 10 of 2,804Source NIH's project files
See all 2,804 nih grantsPapers3,694
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Silent Vehicle: Validating the Biological Signals and Noises of Baculovirus Vectors in Macrophage-Targeted Vaccines. | Vaccines (Basel) | 2026 | 42797636 | PubTator, text mining | PubMed |
| Development and Evaluation of Three Indirect ELISA Methods Based on Novel Recombinant ASFV Antigens for Serological Detection of African Swine Fever. | Pathogens | 2026 | 42796751 | PubTator, text mining | PubMed |
| Evaluation of An I226R and A137R deletion mutant from a genotype I/II recombinant African swine fever virus strain as a live attenuated vaccine in pigs. | Vet Res | 2026 | 42665846 | PubTator, text mining | PubMed |
| Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases. | Ann Rheum Dis | 2026 | 42618420 | PubTator, text mining | PubMed |
| Systems-level insights into age-dependent innate immune responses in influenza B infection. | Microbiol Spectr | 2026 | 42615604 | PubTator, text mining | PubMed |
| Novel Linear B Cell Epitopes of ASFV p54: Screening and Fine-Scale Mapping. | Microorganisms | 2026 | 42513912 | PubTator, text mining | PubMed |
| Non-Cytopathic Mammalian Orthoreovirus Infection Triggers Innate Immune Responses in Human Tonsil-Derived Mesenchymal Stem Cells: Implications for Cell Therapy Quality Control. | Tissue Eng Regen Med | 2026 | 42467368 | PubTator, text mining | PubMed |
| An integrative epigenomic and single-cell framework identifies a prognostic DNA methylation risk score and ZNF638 silencing in urothelial carcinoma. | J Transl Med | 2026 | 42443907 | PubTator, text mining | PubMed |
| 1D-2D hybrid based electrochemical sensor for nano-architected sensing of ASFV p32 - an early phosphoprotein. | Biosens Bioelectron | 2026 | 42425003 | PubTator, text mining | PubMed |
| Type I and II Interferon Signalling Characterizes the Transcriptional Landscape of Sweet Syndrome. | Exp Dermatol | 2026 | 42410891 | PubTator, text mining | PubMed |
1 to 10 of 3,694
See all 3,694 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3433
GET https://conductscience.org/api/genes/v1/3433/patents?page=2